ARTICLE | Company News
Takeda drops diabetes compound fasiglifam
December 27, 2013 1:06 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it is discontinuing development of fasiglifam ( TAK-875) due to concerns about liver safety. The free fatty acid receptor 1 ( FFAR1; GPR40) agonist was...